Arterra Bioscience S.p.A. (ARBS.XMIL) Dividend Analysis
Does Arterra Bioscience S.p.A. (ARBS.XMIL) pay a dividend?
No. Arterra Bioscience S.p.A. (ARBS.XMIL) paid €0.15 per share in fiscal 2025, and no later dividend appears in its filings.
Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
| Fiscal year | Per share | Change |
|---|---|---|
| 2025 | €0.15 | +15.4% |
| 2024 | €0.13 | +30.0% |
| 2023 | €0.10 | 0.0% |
| 2022 | €0.10 |
All 4 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
Dividend is covered by FCF, though with limited buffer, no sustained growth pattern yet.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (73) × 0.40 + Growth (60) × 0.35 + Income (0) × 0.25 = 50
Dividend Yield
—
Per Share (TTM)
€0.15
Payout Ratio
48.7%
3Y CAGR
14.5%
Dividend Safety
Earnings Payout
48.7%
FCF Payout
63.5%
FCF Coverage
1.6x
Dividend Growth
Per Share (TTM)
€0.15
Growth Streak
2 years
3Y CAGR
14.5%
Does Arterra Bioscience S.p.A. (ARBS.XMIL) pay a dividend?
Frequently asked
Does Arterra Bioscience S.p.A. (ARBS.XMIL) pay a dividend?+
No. Arterra Bioscience S.p.A. (ARBS.XMIL) does not currently pay a dividend. The last payment in our data was in 2025, and nothing has been paid since.
How does Arterra Bioscience S.p.A. return cash to shareholders?+
It largely does not. Arterra Bioscience S.p.A. pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Arterra Bioscience S.p.A. afford to pay a dividend?+
On the numbers, yes. Arterra Bioscience S.p.A. generated €2 million of free cash flow, which is about €0.24 per share. If it paid out half of that, the dividend would be roughly €0.12 per share. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Arterra Bioscience S.p.A..
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.